Gene therapy doubles survival in recurrent glioblastoma

An experimental gene therapy essentially doubled the overall survival of patients with recurrent glioblastoma compared to the current standard of care, researchers report.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1M9nXK4